Cosmetic Claims “Misleading” Standard Should Be Articulated By FDA – CTFA
This article was originally published in The Rose Sheet
Executive Summary
FDA's development of a general policy statement on how it determines whether labeling claims for cosmetics and cosmetic-drugs are "inherently misleading" is urged by the Cosmetic, Toiletry and Fragrance Association in Sept. 13 comments to the agency